Northern Trust Corp Humacyte, Inc. Call Options Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HUMA
# of Institutions
181Shares Held
59.9MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$14.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$9.17 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$8.65 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$8.49 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $221M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...